NAMPT and neoplasm: The best candidate hit, FK866, was then validated at biochemical and molecular levels, so evidencing a novel role of this NAMPT inhibitor in promoting—through the production of reactive oxygen species—DNA damage and telomere loss, two events inducing tumor cell death.